PGNX Insider Holders & Insider Ownership - PROGENICS PHARMACEUTICALS INC

List of insiders holdings for PROGENICS PHARMACEUTICALS INC:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Velan Capital L.P. Altiva Management Inc. VENKATARAMAN BALAJI See Explanation of Responses 10% Owner	2020-04-15 15:15:28	8,011,733 0	8,011,733	Form 13D
2	LTE Partners LLC Melkonian Capital Management LLC LTE Management LLC Melkonian Ryan See Explanation of Responses 10% Owner	2019-09-09 18:14:16	1,950,000 0	1,950,000	Form 4
3	MADDON PAUL J Director	2016-04-22 17:09:42	909,891 0	909,891	Form 4/A
4	Baker Mark Robert Chief Executive Officer	2019-03-05 15:49:30	192,500 0	192,500	Form 4
5	JACOBSON PAUL F Director	2008-10-24 16:34:22	125,600 0	125,600	Form 4
6	Nohria Virinder See Explanation of Responses 10% Owner	2019-08-27 15:39:59	110,000 0	110,000	Form 3
7	Summer Jeffery SVP, Digital Technology	2018-03-02 13:57:37	94,875 0	94,875	Form 4
8	Hirt Sheldon Executive VP & General Counsel	2016-03-03 14:34:13	82,500 0	82,500	Form 4
9	Fabbio Patrick CFO	2020-03-04 16:15:02	82,214 0	82,214	Form 4
10	Boyd Thomas A Sr. VP, Product Dev.	2010-07-06 14:16:33	79,436 0	79,436	Form 4
11	Youssoufian Hagop Executive Vice President R&D	2014-03-04 15:32:51	66,000 0	66,000	Form 4
12	Olson William C Senior VP, Research and Develo	2013-04-08 15:58:00	60,000 0	60,000	Form 4
13	Crowley Peter J Director	2019-07-15 09:01:39	55,000 0	55,000	Form 4
14	Lovallo Angelo William JR Vice President Finance	2015-03-04 11:27:33	52,800 0	52,800	Form 4
15	MCKINNEY ROBERT A Senior VP, CFO	2012-03-05 14:23:58	50,000 0	50,000	Form 4
16	YACHMETZ PHILIP K VP, General Counsel	2004-05-05 17:18:23	40,696 200	40,896	Form 4
17	Cooke Terence See Explanation of Responses 10% Owner	2019-08-27 15:25:15	40,000 0	40,000	Form 3
18	ISRAEL ROBERT J Executive Vice President, Medi	2015-06-15 09:32:37	39,050 0	39,050	Form 4
19	PRENTKI RONALD J President	2005-02-17 18:27:58	35,672 0	35,672	Form 4
20	Kremer Alton B VP, Clinical Research	2008-04-03 17:09:57	28,173 0	28,173	Form 4
21	KISHBAUCH MICHAEL D Director	2019-07-15 09:02:03	25,000 0	25,000	Form 4
22	WILLIAMS NICOLE Director	2019-07-15 09:02:33	25,000 0	25,000	Form 4
23	SCHEINBERG DAVID A Director	2019-07-15 09:02:21	25,000 0	25,000	Form 4
24	GOFF STEPHEN P Director	2013-06-20 15:43:27	20,000 0	20,000	Form 4
25	BAKER CHARLES A Director	2012-06-14 14:57:15	10,000 0	10,000	Form 4
26	BRINER KURT W Director	2012-06-14 14:56:45	10,000 0	10,000	Form 4
27	DALTON MARK F Director	2011-07-06 19:01:17	10,000 0	10,000	Form 4
28	Ferrante Karen Jean Director	2020-06-23 16:47:07	0 0	0	Form 4
29	Das Asha Chief Medical Officer	2020-06-23 16:49:43	0 0	0	Form 4
30	Osorio Benedict COO	2020-06-23 16:49:25	0 0	0	Form 4
31	Tenbarge Bryce SVP, Commercial	2020-06-23 16:49:04	0 0	0	Form 4
32	Wong Vivien EVP, Development	2020-06-23 16:48:47	0 0	0	Form 4
33	Mims David W. Interim CEO and Interim CFO	2020-06-23 16:48:25	0 0	0	Form 4
34	Ber Gerard Director	2020-06-23 16:48:05	0 0	0	Form 4
35	Campbell Bradley L Director	2020-06-23 16:47:46	0 0	0	Form 4
36	Ende Eric J Director	2020-06-23 16:47:26	0 0	0	Form 4
37	MacDougall Ann L. Director	2020-06-23 16:46:47	0 0	0	Form 4
38	Maeusli Heinz Christoph Director	2020-06-23 16:46:24	0 0	0	Form 4
39	Sarpangal Deepak See Explanation of Responses 10% Owner	2019-08-27 15:29:07	0 0	0	Form 3
40	Broadfin Healthcare Master Fund Ltd Broadfin Capital LLC KOTLER KEVIN 10% Owner	2018-02-13 16:57:52	0 0	0	Form 13G

Insider Holders & Insider Ownership - PROGENICS PHARMACEUTICALS INC (PGNX)